These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8389015)

  • 1. Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction.
    Drüeke TB
    Nephrol Dial Transplant; 1993; 8 Suppl 1():12-6. PubMed ID: 8389015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aluminum and iron deposition in dialysis patients].
    Kurihara S; Marumo F
    Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
    [No Abstract]   [Full Text] [Related]  

  • 3. Adynamic bone disease in uremia: may it be idiopathic? Is it an actual disease?
    Fournier A; Morinière P; Cohen Solal ME; Boudailliez B; Achard JM; Marie A; Sebert JL
    Nephron; 1991; 58(1):1-12. PubMed ID: 1857463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aluminum and iron deposition in dialysis patients].
    Kashiwagi T; Kurihara S
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():400-5. PubMed ID: 15250334
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminium interference in the treatment with recombinant human erythropoietin.
    Casati S; Campise M; Ponticelli C
    Contrib Nephrol; 1990; 87():87-94. PubMed ID: 2093544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance to EPO. Hyperfunction of the parathyroid glands].
    Kokot F
    Przegl Lek; 1995; 52(3):86-7. PubMed ID: 7644680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum-induced anemia.
    Kaiser L; Schwartz KA
    Am J Kidney Dis; 1985 Nov; 6(5):348-52. PubMed ID: 3904427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanism of resistance to erythropoietin.
    Casadevall N
    Nephrol Dial Transplant; 1995; 10 Suppl 6():27-30. PubMed ID: 8524490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a link between erythropoietin therapy and adynamic bone disease?
    Smans KA; Van Landeghem FG; D'Haese PC; Couttenye MM; De Broe ME
    Nephrol Dial Transplant; 1996 Jul; 11(7):1248-9. PubMed ID: 8672017
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P; Wedard BM; Bonucci E
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the complex aluminium and iron relationship.
    Cannata JB; Diaz López JB
    Nephrol Dial Transplant; 1991; 6(9):605-7. PubMed ID: 1745383
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
    Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
    South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminium toxicity: its relationship with bone and iron metabolism.
    Cannata Andía JB
    Nephrol Dial Transplant; 1996; 11 Suppl 3():69-73. PubMed ID: 8840317
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term persistence of improvement of renal anaemia in spite of discontinued erythropoietin treatment.
    Wiecek A; Kokot F; Marcinkowski W
    Nephron; 1995; 69(4):489-90. PubMed ID: 7777122
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of inhibitors of heme synthesis and bone marrow erythroid colony forming cells in the mechanism of anemia of renal insufficiency.
    Fisher JW; Moriyama Y; Rege AB; Tornyos K; Lertora JJ
    Proc Clin Dial Transplant Forum; 1974; (4):141-6. PubMed ID: 4468411
    [No Abstract]   [Full Text] [Related]  

  • 20. Adynamic bone disease--is it actually a disease?
    Fournier A; Morinière P; Marié A
    Nephrol Dial Transplant; 1995; 10(4):454-7. PubMed ID: 7623985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.